| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,909 | 19,907 | 19,113 | 24,022 | | Cost of Revenue | 9,636 | 10,039 | 9,783 | 13,528 | | | Gross Profit | 10,273 | 9,868 | 9,330 | 10,494 | | | Operating Expenses | | Research Development | 1,787 | 1,384 | 1,595 | 1,843 | | Selling General and Administrative | 12,400 | 10,541 | 8,795 | 10,712 | | Non Recurring |
-
|
-
|
-
| 3,348 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,914) | (2,057) | (1,060) | (5,409) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 161 | 61 | (52) | (414) | | Earnings Before Interest And Taxes | (3,800) | (2,062) | (1,179) | (5,754) | | Interest Expense | 79 | 90 | 145 | 105 | | Income Before Tax | (3,879) | (2,152) | (1,324) | (5,859) | | Income Tax Expense | (215) | 401 | (41) | (621) | | Minority Interest | 175 | 303 | 295 | 335 | | | | Net Income From Continuing Ops | (4,262) | (2,250) | (988) | (4,903) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,489) | (2,250) | (988) | (4,903) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,489) | ($2,250) | ($988) | ($4,903) |
|
0.02% Nasdaq 
Income Statement
